DIRS.INFO The most relevant business & tech news

The rule will make medication abortion, which accounts for more than half of U.S. abortions, more accessible in states where abortion remains legal, but its impact in states that have banned abortion will be limited. Most significantly, the FDA's new regulation will not help patients get abortion pills in states that have banned abortion, said Amanda Allen of the Lawyering Project, a legal group that defends abortion rights. Nonetheless, Allen said, the rule could make it easier to travel out of state for a medication abortion. Currently, a patient seeking a medication abortion in another state must both obtain the prescription and the pill in that state. Some conservative policy groups and lawmakers have proposed laws that would make it a crime to help someone travel to another state for abortion or mail them abortion pills.

☆ Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
▼ + stars: | 2022-12-29 | by ( Jonathan Stempel | ) www.reuters.com time to read: +1 min

NEW YORK, Dec 28 (Reuters) - Novartis AG (NOVN.S) said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the United States of generic versions of its Exforge hypertension drug. The class-action litigation stemmed from a 2011 licensing agreement between Novartis and Endo International Plc's (ENDPQ.PK) Par Pharmaceutical unit. Novartis's annual U.S. sales of brand-name Exforge exceeded $400 million before generic versions were sold, court papers show. The case is In re Novartis and Par Antitrust Litigation, U.S. District Court, Southern District of New York, No. Reporting by Jonathan Stempel in New York; Editing by Muralikumar Anantharaman and Bradley PerrettOur Standards: The Thomson Reuters Trust Principles.

☆ Navigating the e-bike boom with America's outdated infrastructure
▼ + stars: | 2022-12-29 | by ( Liam Mays | ) www.cnbc.com time to read: +2 min

Electric bikes are becoming increasingly popular around the world. This speed is often blamed for the increased dangers that are seen with e-bikes compared with those of traditional bikes. "E-bikes are three times more likely to result in a hospitalization if an injury occurs compared to traditional bikes," DiMaggio said. "Whether that's pedestrians, regular cyclists or electric bikes." "The big difference that you see here in the Netherlands compared to most other places, with very few exceptions, is that everybody cycles here.

☆ Stocks making the biggest moves premarket: Rite Aid, Nike, FedEx and others
▼ + stars: | 2022-12-21 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines before the bell:Rite Aid (RAD) – Rite Aid jumped 8.4% in the premarket after reporting a smaller-than-expected loss and revenue that beat Wall Street forecasts, helped by accelerated sales growth at its retail operations. Nike (NKE) – Nike surged 11.6% in the premarket after the athletic footwear and apparel maker reported better-than-expected quarterly results and raised its revenue forecast. FedEx (FDX) – FedEx rallied 4.5% in premarket trading following its quarterly results, which saw profit beat consensus but sales fell short of analyst estimates. BlackBerry (BB) – BlackBerry gained 1% in premarket trading after its quarterly revenue beat estimates on strong demand for the company's automotive and security software. BlackBerry also reported a smaller-than-expected quarterly loss.

☆ Housing slump to continue but some hopeful signs ahead
▼ + stars: | 2022-12-18 | by ( Paul R. La Monica | ) edition.cnn.com time to read: +6 min

While that’s already had a negative impact on the housing market, we’ll get more details this week about how much worse the damage has become. A long list of housing data is on tap. On Tuesday the US Census Bureau will report housing starts and building permits figures for November, followed by Friday’s release of new home sales data for the same month. Housing market was frothy, but not a bubbleOthers in the industry are cautiously optimistic as well. That all amounts to a few good reasons why the housing market could avoid a severe and prolonged slump.

☆ Markets close out the week lower, as investors brace themselves for more rate hikes next year
▼ + stars: | 2022-12-16 | by ( Zev Fima | ) www.cnbc.com time to read: +4 min

But what irked markets was Fed Chair Jerome Powell's indication the Fed could continue to raise rates for longer to bring inflation under control. The S & P 500 lost around 2.25% for the week, closing out Friday down more than 1%. Under the hood, the consumer discretionary sector led to the downside this week, followed by financials and technology. Initial jobless claims for the week ending Dec. 10 came in at 211,000, a decrease of 20,000 from the prior week and below expectations of 232,000. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ These stocks are cheap heading into 2023, and analysts love them
▼ + stars: | 2022-12-04 | by ( Fred Imbert | ) www.cnbc.com time to read: +3 min

However, this sell-off may have opened buying opportunities among some of Wall Street analysts' favorite names. Amazon made the list, trading at a 31.6% discount to its average five-year forward P/E multiple. The stocks is trading at a more than 50% discount to its average five-year forward valuation and has buy ratings from more than three-quarters of analysts covering it. The former is trading 82% below its average five-year forward valuation, while Delta is 77% below. Delta, meanwhile, has dropped 10% in 2022, but the average analyst price target on the airline implies upside of 35%.

☆ Another tech bubble bursts: 2022 has been brutal for Silicon Valley workers
▼ + stars: | 2022-11-27 | by ( David Ingram | David Ingram Covers Tech For Nbc News. | ) www.nbcnews.com time to read: +28 min

Gem: 100A maker of recruiting software, the startup cut a third of its workforce Nov. 1, The Information reported. HealthCare.com: 149The health insurance marketplace announced the job cuts Aug. 3, Miami Inno reported, citing state regulatory filings. Fabric: 120The robotics startup said July 13 that it was layoffing off 40% of them, TechCrunch reported, citing company confirmation. It affected about 300 people, the Silicon Valley Business Journal reported, citing company confirmation. Policygenius: 170The online insurance company cut about 25% of its staff, Axios reported June 6, citing company confirmation.

The following are major companies that were accused of contributing to the crisis, and settlements or judgments involving those companies. Teva Pharmaceutical Industries Ltd (TEVA.TA)-In November, finalized claims nationwide for $4.25 billion, some of which is to be paid as a supply of the overdose-reversing drug naloxone. AbbVie Inc (ABBV.N)-In November, finalized a $2.37 billion nationwide settlement resolving claims against Allergan, a company it acquired in 2020. Endo International Plc (ENDPQ.PK)-Reached a $450 million settlement with more than 30 states as part of a bankruptcy filing in August. Mallinckrodt Plc (MNK.A)-Reached a $1.7 billion nationwide settlement as part of its bankruptcy reorganization plan, approved in February.

Almost all the funds, some $7.8 billion, flowed between Binance and Iran's largest crypto exchange, Nobitex, according to a review of data from leading U.S. blockchain researcher Chainalysis. The scale of Binance's Iranian crypto flows – and the fact that they are continuing – has not been previously reported. The total volume of Iranian transactions flowing through Binance is far greater than through any other exchange, the data show. The vast majority of the $8 billion in Iranian crypto transactions identified by Reuters involved the main Binance exchange. This October, the Treasury fined Seattle-based crypto exchange Bittrex $24 million for violating sanctions on Iran and other countries by processing crypto transactions worth over $260 million.

Walmart has agreed to pay $3.1 billion, mostly up front, according to two people familiar with the matter. The proposed settlement, which would be the first nationwide deal with retail pharmacy companies, follows nationwide opioid settlements with drugmakers and distributors totaling more than $33 billion. CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share. The agency has attributed much of the recent rise in overdose cases to illegally manufactured fentanyl, a powerful synthetic opioid. A congressional report last month put the economic toll of the opioid crisis in 2020 alone at $1.5 trillion.

☆ Stocks making the biggest moves midday: Apple, Amazon, Intel and more
▼ + stars: | 2022-10-28 | by ( Carmen Reinicke | ) www.cnbc.com time to read: +5 min

Apple – Shares of Apple jumped 8% after the technology giant beat both top and bottom line estimates when it reported earnings results for its latest quarter. Amazon – Shares of Amazon slipped 9% Friday after the retailer on Thursday reported quarterly revenue that fell short of Wall Street's expectations. T-Mobile – T-Mobile stock jumped 6% after the telecom company reported the largest jump in subscriber numbers since 2020, when it merged with Sprint. Pinterest – Pinterest rose 8% after the social media company beat earnings expectations and reported more monthly users than analysts forecast. The medical equipment company reported quarterly results on Thursday, posting revenue that slightly beat expectations, according to consensus estimates on StreetAccount.

☆ Morning Bid: Meta averse, ECB decides and CS slides
▼ + stars: | 2022-10-27 | by ( ) www.reuters.com time to read: +4 min

A look at the day ahead in U.S. and global markets from Mike Dolan. Meta added a deep pothole to an already bumpy U.S. earnings season - another obstacle to a market pumped-up by bets of some central bank relief on the horizon as G7 economies slow. read moreWith Apple (AAPL.O) and Amazon reporting later on Thursday, sentiment toward tech giants remains on edge. But after two-week, trough-to-peak bounce of almost 10%, global stock indices (.MIWD00000PUS) struggled to make much headway for the second session on Thursday. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

☆ Inflation Has Sparked Record Credit-Card Debt: How Things Could Get Messy
▼ + stars: | 2022-10-27 | by ( Dion Rabouin | ) www.wsj.com time to read: 1 min

E39Treasury Bonds May Be 2022’s Coolest Investment. Here’s Why. Many new investors don’t know much about bond investing or how much they can earn with low risk by investing in U.S. government bonds. WSJ’s Dion Rabouin seeks to change that with a rad new commercial appealing to America’s youth. Illustration: David Fang

☆ Analysts love these stocks set to report earnings in the week ahead
▼ + stars: | 2022-10-23 | by ( Fred Imbert | ) www.cnbc.com time to read: +3 min

One approach that could help is by looking at the names most beloved by analysts heading into earnings. The e-commerce giant is slated to report earnings Thursday. Alphabet, which is set to report earnings Tuesday, has struggled in 2022, losing 30% in that time. The company is slated to report earnings Thursday. ServiceNow and Alexandria Real Estate have the most buy rating from analysts covering them at 83.5% each.

☆ One office building is trying a radical new ploy to lure Google and other firms to Brooklyn
▼ + stars: | 2022-10-20 | by ( Jordan Pandy | ) www.businessinsider.com time to read: +5 min

An office building in Williamsburg, Brooklyn, is slashing rents and offering flexible leases. At 25 Kent Ave., it's offering 50% off to lure tech and media firms that are attracted to Manhattan. In July 2019, Rubenstein opened an eight-story, 511,000-square-foot office building at 25 Kent Ave. in Williamsburg, Brooklyn. Bilyana DimitrovaTarget tenants include Google, Facebook, Amazon, and companies that have over 500,000 square feet of office space in Manhattan. People who work at 25 Kent have access to its fitness center.

People are seen shopping in a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File PhotoOct 13 (Reuters) - Walgreens Boots Alliance Inc (WBA.O) reported a better-than-expected quarterly profit on Thursday, as higher UK retail sales helped more than offset waning COVID vaccination demand. Shares of Walgreens, one of the largest U.S. pharmacies, rose nearly 3% amid bigger market weakness after the company also forecast a "better-than-feared" full-year profit. Register now for FREE unlimited access to Reuters.com RegisterDespite inflationary challenges, Walgreens saw an uptick in retail sales, helped by higher demand for health and wellness as well as beauty products. The company also benefited from its Walgreens Health segment, which was launched last year as part of Walgreens' efforts to diversify its business.

☆ Walgreens boosted by higher retail sales, nascent consumer health business
▼ + stars: | 2022-10-13 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Andrew Kelly/File PhotoOct 13 (Reuters) - Walgreens Boots Alliance Inc (WBA.O) reported a better-than-expected quarterly profit on Thursday, as higher UK retail sales and strength in its newly launched consumer health business helped offset waning COVID vaccination demand. Shares of Walgreens, one of the largest U.S. pharmacies, rose nearly 7% in premarket trading after the company also forecast a higher full-year profit. Evercore ISI analyst Elizabeth Anderson said though the results were mixed, the full-year forecast was "much better than feared". The company also benefited from its Walgreens Health segment, which was launched last year as part of Walgreens' efforts to diversify its business. For 2023, Walgreens said its expects strong growth in its core business to offset waning demand for COVID related products and services.

☆ These retail chains may not survive a recession
▼ + stars: | 2022-10-13 | by ( Nathaniel Meyersohn | ) edition.cnn.com time to read: +4 min

New York CNN Business —America’s retail chains have proven surprisingly strong during the pandemic. At the beginning of the pandemic, stores temporarily closed to halt the spread of Covid-19 and retail sales tumbled. “That wave of defaults effectively flushed out a lot of debt and unprofitable stores from the sector,” Sokolyanska said. Retail sales quickly recovered thanks to federal stimulus checks, growing personal savings accounts and pent-up consumer demand. Retail sales remain above pre-pandemic levels and more stores have announced openings than closings this year.

☆ Lab tie-up would have multiple ailments
▼ + stars: | 2022-10-11 | by ( ) www.reuters.com time to read: +2 min

LONDON, Oct 11 (Reuters Breakingviews) - Qiagen (QIA.DE) may once again find itself at the centre of an M&A drama. The $10 billion German lab tester is in talks with $10 billion U.S. life-science company Bio-Rad (BIO.N), the Wall Street Journal reported on Monday. Any deal would follow Thermo Fisher Scientific’s (TMO.N) failed attempt to buy Qiagen for 11.3 billion euros ($11 billion) back in 2020. Regulators in the United States and Europe have been increasingly wary of tie-ups that could lead to higher prices. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

☆ Diagnostics firm Bio-Rad in talks to merge with Qiagen - WSJ
▼ + stars: | 2022-10-10 | by ( ) www.reuters.com time to read: +1 min

Oct 10 (Reuters) - California-based diagnostics company Bio-Rad Laboratories (BIO.N) is in talks to merge with Qiagen NV (QIA.DE), the Wall Street Journal reported on Monday, citing people familiar with the matter. U.S-listed shares of Qiagen rose 8% while Bio-Rad fell nearly 10% after the report. Register now for FREE unlimited access to Reuters.com RegisterBio Rad, which manufactures and supplies products such as laboratory apparatus, instruments and diagnostics, has a market-cap of $12.85 billion. Both Qiagen and Bio-Rad did not immediately respond to Reuters' requests for comments. Register now for FREE unlimited access to Reuters.com RegisterReporting by Bhanvi Satija in Bengaluru; Editing by Vinay DwivediOur Standards: The Thomson Reuters Trust Principles.

☆ Bio-Rad Laboratories in Talks to Combine With Qiagen
▼ + stars: | 2022-10-10 | by ( Miriam Gottfried | Ben Dummett | ) www.wsj.com time to read: 1 min

Qiagen has developed technologies that isolate and process DNA, RNA and proteins from blood, tissue and other materials. Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter. The talks have been going on for a while but any agreement isn’t likely for another few weeks or more—and there may not be one.

☆ Wall Street analysts’ favorite stocks for the fourth quarter include a casino name that could double
▼ + stars: | 2022-10-01 | by ( Fred Imbert | ) www.cnbc.com time to read: +4 min

The fourth quarter is finally here, much to the relief of many investors who took a beating in the previous three-month period. Stocks were battered last quarter as the Federal Reserve doubled down on its aggressive monetary policy stance to fight persistently high inflation. Wall Street analysts are to here to help, recommending several stocks that could do well going forward. On top of that, 75% of analysts covering the stock rate it as a buy, FactSet data shows. Both stocks have buy ratings from nearly two-thirds of analysts covering them.

☆ Stocks making the biggest moves premarket: Apple, CarMax, Bed Bath & Beyond and more
▼ + stars: | 2022-09-29 | by ( Peter Schacknow | ) www.cnbc.com time to read: +3 min

CarMax (KMX) – CarMax shares slumped 12.1% in premarket trading after the auto retailer missed estimates on both the top and bottom lines for its latest quarter. Bed Bath & Beyond (BBBY) – The housewares retailer posted a wider-than-expected quarterly loss and sales that fell short of consensus. MillerKnoll (MLKN) – MillerKnoll fell 7.3% in the premarket after its quarterly profit beat analyst estimates, although revenue fell short. Jefferies Financial (JEF) – Jefferies shares rose 1.6% in premarket action after posting a better-than-expected quarterly profit. The purchases came after Occidental shares lost about 20% of their value in less than a month.

☆ Stocks week ahead: Intel is the Dow's biggest loser
▼ + stars: | 2022-09-25 | by ( Paul R. La Monica | ) edition.cnn.com time to read: +6 min

Shares of Intel (INTC) are down more than 45% this year, making it the biggest dog of the Dow. Intel (INTC) is struggling despite well-publicized plans to build more plants in the United States and hire more at home. To be fair, Intel is not the only chip company that’s having a tough time this year. But longer-term, I think Intel will right the ship,” said Jeff Travis, portfolio manager of Oak Associates Funds. Travis does think that semiconductor stocks are still a good “secular growth industry” and that valuations are now attractive given how sharply the stocks have fallen.

Search resuls for: "Rad"

25 mentions found